Assisted Reproductive Technology (ART) Market Analysis

Assisted Reproductive Technology Market Analysis

As per type, the industry is classified into product and procedure. The report cites that the assisted reproductive technology market share from the procedure segment accounted for more than USD 33 billion in revenue in 2022 and is estimated to witness substantial growth from 2023 to 2032. Soaring live birth rates facilitated by fresh non-donors are anticipated to bolster the need for ART procedures. Notably, research suggests that over 2.5 million cycles are performed globally in a year. Thus, the high adoption of in-vitro fertilization technology and IVF procedures is likely to fuel segment expansion.
 

The fertility clinics end-user/provider segment held over 54% share in the assisted reproductive technology market in 2022 and is projected to expand notably through 2032. Advancements in assisted reproductive technologies, coupled with the growing integration of AI and robotic technologies, are raising the demand for infertility treatments. Additionally, favorable government initiatives are expected to stimulate segment progress.
 

According to the report, the North America assisted reproductive technology market is estimated to reach a valuation of over USD 19.5 billion by 2032. This is attributed to the increasing infertility rate, coupled with the growing acceptance of fertility procedures, such as IVF and ART, among patients across the region. As per research, infertility affects around 11% of women and 9% of males of reproductive age in the U.S. Moreover, technological advancements and rising disposable income are expected to boost the uptake of fertility services in North America, which is likely to be profitable for the regional business.